Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance.

Forbes contributors publish independent expert analyses and insights. Ge Bai is professor of accounting & health policy at Johns Hopkins. Using data from Kythera Labs, a healthcare data technology ...

In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers. When Elon Musk was at Davos last week, an interviewer asked him if he thought aging ...

This is read by an automated voice. Please report any issues or inconsistencies here. Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and ...

When I asked Manisha to describe her gender identity, she gave a simple answer: “Meh.” “I don’t have a gender identity,” Manisha explained. “I get that other people look at me and see a woman but, for ...

The right of transgender minors to access gender-affirming care has sparked debate across the United States. With a US Supreme Court ruling upholding Tennessee’s ban on the practice, experts say, ...

Aging is the primary risk factor for numerous life-threatening diseases and has long been a central focus of biological research. Epigenetic reprogramming, a process that can modulate cell fate and ...

To many, it seems obvious that having women well-represented in the workplace would be a good thing. After all, they make up more than half the population and, in many cases, they are contributing or ...

Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of T cells, scientists at the VIB-KU Leuven Center for Cancer Biology and ...

For those hoping to cure death, and they are legion, a 2016 experiment at the Salk Institute for Biological Studies in San Diego has become liminal — the moment that changed everything. The experiment ...